|
|
Showing 1 - 1 of
1 matches in All Departments
The Guest Editors of this issue of Urologic Clinics of North
America have put together a comprehensive collection of articles
that provides the current knowledge on urologic cancer
immunotherapy. Expert authors have contributed clinical review
articles on the following topics: Era of personalized vaccines for
GU cancers; TCR and dendritic vaccine platforms for GU cancers;
Neo-adjuvant platforms for GU cancer immunotherapy; Immune-editing
in Cancer: Role of tumor microenvironment and immune-suppressive
pathways in localized and aggressive disease; Clinical integration
of neo-adjuvant platforms for prostate cancer immunotherapy;
Immunotherapy for muscle and non-muscle invasive bladder cancer:
BCG and beyond; Immunotherapy for metastatic bladder cancer;
Immunotherapy options for metastatic castrate-resistant prostate
cancer; Role of tissue infiltrating lymphocytes: Understanding TCR;
Therapeutic platforms for IPSC-derived CAR-T; Immune-suppression in
prostate cancer: Underlying causes and influence on response to
immunotherapy; and Racial disparity in response to immunotherapy.
Urologists will come away with the most current information they
need to improve outcomes in the urologic cancer patient.
|
You may like...
North and South
Elizabeth Gaskell
Paperback
(2)
R250
R231
Discovery Miles 2 310
The Kingdom
Jo Nesbo
Paperback
(1)
R371
Discovery Miles 3 710
The Fourth Boy
Andrew Robert Wilson
Paperback
R380
R351
Discovery Miles 3 510
Shadow State
Andy McNab
Paperback
R335
R299
Discovery Miles 2 990
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.